NEWHALL CHARLES W III 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
NEWHALL CHARLES W III
Director
Transactions
- Award
Common Stock
2026-02-24+4,475→ 124,119 total - Disposition to Issuer
Restricted Stock Unit
[F1][F2]2026-02-24−4,475→ 0 total→ Common Stock (4,475 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F2]These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.
Signature
/s/ Timothy C. Dec, as attorney-in-fact|2026-02-25